Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12AZY | ISIN: SE0005497732 | Ticker-Symbol: 7JK
Frankfurt
01.11.24
15:29 Uhr
5,620 Euro
-0,020
-0,35 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
EQL PHARMA AB Chart 1 Jahr
5-Tage-Chart
EQL PHARMA AB 5-Tage-Chart

Aktuelle News zur EQL PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.10.Invitation to presentation in connection with EQL Pharma's interim report, second quarter, 2024/25-
19.08.EQL Pharma AB: Bulletin from the annual general meeting in EQL Pharma AB on 19 August 202457Today, on 19 August 2024, the annual general meeting was held in EQL Pharma AB. A summary of the adopted resolutions follows below. Resolution on adoption of accounts and allocation of the company's...
► Artikel lesen
08.08.EQL Pharma AB: Interim Report April - June 202459Sales and operating profit growth, new products added to the pipeline April - June Consolidated sales during the first quarter, April to June amounted to SEK 82.8 (56.2) million, an increase of 47%....
► Artikel lesen
16.07.Notice of annual general meeting in EQL Pharma AB1
15.07.Invitation to presentation in connection with EQL Pharma's interim report, first quarter, 2024/251
05.07.EQL PHARMA: Mellozzan[® ](melatonin) has gained marketing approval in Switzerland1
04.07.Nasdaq Stockholm welcomes EQL Pharma to the Main Market196Stockholm, Jul 4, 2024 - Nasdaq (Nasdaq: NDAQ) announces that trading in the shares of EQL Pharma AB (ticker name: EQL) will commence today on the Nasdaq Stockholm Main Market. EQL Pharma is a Small...
► Artikel lesen
04.07.Trading in EQL Pharma's shares on Nasdaq Stockholm commences today2
02.07.Nasdaq Stockholm AB: Listing of EQL Pharma AB on Nasdaq Stockholm183On request of EQL Pharma AB, company registration number 556713-3425, Nasdaq Stockholm has admitted the company's shares to trading with effect from July 4, 2024. As per today's date the company has...
► Artikel lesen
28.06.EQL Pharma AB publishes prospectus for list change to Nasdaq Stockholm1
28.06.Spotlight Stock Market: Market Notice 138/24 - EQL Pharma AB will be delisted after close of the market on July 3, 20241
27.06.Nasdaq Stockholm AB: Listing of EQL Pharma AB on Nasdaq Stockholm177Nasdaq Stockholm AB has assessed that EQL Pharma AB, company registration number 556713-3425, fulfills Nasdaq Stockholm's listing requirements. Provided that EQL Pharma AB applies for admission to trading...
► Artikel lesen
12.06.EQL Pharma AB has been approved for listing on Nasdaq Stockholm1
27.05.EQL Pharma's CEO increases his holding in the company1
14.05.EQL PHARMA: Year-end Report April 2023 - March 20241
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1